2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$118.73+$3.24 (+2.81%)
Price as of Jun 23, 2026 3:18 PM EDT- $285.2BMarket Cap
- 48.88%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$118.73+$3.24 (+2.81%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 65.0B +1.31% | 64.2B +6.74% | 60.1B +1.40% | 59.3B +21.72% | |
Cost of Revenue | 16.4B +7.83% | 15.2B -5.79% | 16.1B -7.38% | 17.4B +27.78% | |
Gross Profit | 48.6B -0.71% | 49.0B +11.33% | 44.0B +5.06% | 41.9B +19.37% | |
Sales and Marketing Expense | 10.7B -0.77% | 10.8B +370.26% | 2.3B -77.10% | 10.0B +4.24% | |
Research and Development Expense | N/A N/A | -17.9B -41.25% | -30.5B -325.35% | 13.5B +10.64% | |
Depreciation and Amortization Expense | 3.0B +44.72% | 2.1B +15.10% | 1.8B +0.22% | 1.8B +15.59% | |
Total Operating Expenses | 16.4B +7.83% | 15.2B -5.79% | 16.1B -7.38% | 17.4B +27.78% | |
Operating Profit | 21.1B +5.67% | 19.9B +5,361.92% | 365.0M -97.78% | 16.4B +18.48% | |
Interest Income | 343.0M -17.35% | 415.0M +13.70% | 365.0M +132.48% | 157.0M +336.11% | |
Interest Expense | N/A N/A | N/A N/A | -1.1B +19.13% | -962.0M +19.35% | |
Interest Income and Expense and Net | 343.0M -17.35% | 415.0M +153.14% | -781.0M -597.45% | 157.0M +336.11% | |
Total Nonoperating Income and Expense | -151.0M -729.17% | 24.0M +105.15% | -466.0M -68.95% | -1.5B -211.93% | |
Income before Taxes | 21.1B +5.67% | 19.9B +5,361.92% | 365.0M -97.78% | 16.4B +18.48% | |
Income Taxes | 2.8B +0.04% | 2.8B +247.60% | -1.9B -199.01% | 1.9B +26.10% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 18.3B +6.64% | 17.1B +4,589.59% | 365.0M -97.49% | 14.5B +11.27% | |
Net Income from Continuing Operations Applicable to Common | 21.1B +5.67% | 19.9B +5,361.92% | 365.0M -97.49% | 14.5B +17.61% | |
Basic EPS and Net Income | 7.30 +7.99% | 6.76 +4,728.57% | 0.14 -97.56% | 5.73 +11.05% | |
Diluted EPS and Net Income | 7.28 +8.01% | 6.74 +4,714.29% | 0.14 -97.55% | 5.71 +11.09% | |
Basic Weighted Average Shares | 2.5B -1.18% | 2.5B -0.20% | 2.5B +0.20% | 2.5B +0.08% | |
Diluted Weighted Average Shares | 2.5B -1.34% | 2.5B -0.24% | 2.5B +0.20% | 2.5B +0.16% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 14.6B +9.99% | 13.2B +93.57% | 6.8B -46.11% | 12.7B +56.79% | |
Short-Term Investments | 0 -100.00% | 447.0M +77.38% | 252.0M -49.40% | 498.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 14.6B +6.40% | 13.7B +92.99% | 7.1B -46.23% | 13.2B +62.94% | |
Total Current Assets | 43.5B +12.21% | 38.8B +20.56% | 32.2B -9.95% | 35.7B +18.03% | |
Accumulated Depreciation | 21.9B +14.40% | 19.2B +4.87% | 18.3B +1.56% | 18.0B -1.14% | |
Property and Plant and Equipment and Net | 25.3B +6.46% | 23.8B +3.16% | 23.1B +7.60% | 21.4B +11.12% | |
Total Long-Term Assets | 18.8B +17.29% | 16.0B +33.74% | 12.0B -46.53% | 22.4B +14.19% | |
Total Assets | 136.9B +16.87% | 117.1B +9.78% | 106.7B -2.28% | 109.2B +3.28% | |
Income Taxes Payable | 6.2B +16.30% | 5.3B +50.60% | 3.5B -6.90% | 3.8B -18.95% | |
Total Short-Term Debt | 2.6B -2.27% | 2.6B +93.08% | 1.4B -29.50% | 1.9B -19.32% | |
Total Current Liabilities | 28.3B -0.33% | 28.4B +10.61% | 25.7B +6.00% | 24.2B +1.54% | |
Total Long-Term Debt | 46.8B +35.66% | 34.5B +2.31% | 33.7B +17.18% | 28.7B -6.34% | |
Total Long-Term Liabilities | 7.7B +18.92% | 6.5B -26.47% | 8.8B +5.63% | 8.3B -11.78% | |
Total Liabilities | 28.3B -0.33% | 28.4B +10.61% | 25.7B +6.00% | 24.2B +1.54% | |
Retained Earnings | 73.1B +15.87% | 63.1B +17.02% | 53.9B -11.76% | 61.1B +13.75% | |
Total Stockholders Equity | 52.6B +13.59% | 46.3B +23.24% | 37.6B -18.29% | 46.0B +20.45% | |
Total Shares Outstanding | 3.6B 0.00% | 3.6B 0.00% | 3.6B 0.00% | 3.6B 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 16.5B -23.27% | 21.5B +65.06% | 13.0B -31.89% | 19.1B +35.34% | |
Capital Expenditures | 4.1B +21.95% | 3.4B -12.71% | 3.9B -11.96% | 4.4B -1.35% | |
Cash from Investing Activities | -13.7B +77.67% | -7.7B -45.08% | -14.1B +183.93% | -5.0B -70.04% | |
Dividends Paid | 8.2B +4.29% | 7.8B +5.31% | 7.4B +6.18% | 7.0B +6.08% | |
Cash from Financing Activities | -1.9B -72.67% | -7.0B +46.20% | -4.8B -47.25% | -9.1B -451.68% | |
Financials Ratio | |||||
Gross Margin | 74.80% -1.99% | 76.32% +4.30% | 73.17% +3.60% | 70.63% -1.93% | |
Operating Margin | 32.41% +4.30% | 31.07% +5,016.67% | 0.61% -97.81% | 27.74% -2.66% | |
Return on Assets | 14.37% -6.03% | 15.30% +4,423.36% | 0.34% -97.50% | 13.52% +2.16% | |
Return on Equity | 36.91% -9.56% | 40.81% +4,571.59% | 0.87% -97.47% | 34.50% -16.06% | |
Revenue Growth | 1.31% -80.51% | 6.74% +380.41% | 1.40% -93.54% | 21.72% +1,368.23% | |
Current Ratio | 1.54 +12.58% | 1.36 +8.99% | 1.25 -15.04% | 1.47 +16.24% | |
Cash Ratio | 0.51 +10.37% | 0.47 +75.02% | 0.27 -49.17% | 0.52 +54.44% | |
Debt-to-Equity Ratio | 0.94 +17.05% | 0.80 -14.10% | 0.93 +39.79% | 0.67 -23.02% | |
Debt-to-Assets Ratio | 0.36 +13.76% | 0.32 -3.56% | 0.33 +16.86% | 0.28 -10.22% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow